Antibiotics (General)
- amoxicillin (Amoxil, Trimox, Wymox)
- amoxicillin/potassium clavulanate (Augmentin)
- ampicillin (Omnipen, Principen, Totacillin, Marcillin)
- azithromycin (Zithromax)
- bacampicillin (Spectrobid)
- carbenicillin indanyl sodium (Geocillin)
- chloramphenicol (Chloromycetin Kapseals)
- cinoxacin (Cinobac)
- clarithromycin (Biaxin)
- clindamycin (Cleocin)
- clofazimine (Lamprene)
- cloxacillin sodium (Cloxapen)
- colistin sulfate (Coly-Mycin S)
- dapsone
- dicloxacillin sodium (Dycill, Dynapen, Pathocil)
- dirithromycin (Dynabac)
- erythromycin (E-Base, Ilosone, EryPed, E.E.S., Ery-Tab, E-Mycin, Eryc, Erythrocin, PCE )
- fosfomycin tromethamine (Monurol)
- kanamycin (Kantrex)
- lincomycin (Lincocin)
- metronidazole (Flagyl, Protostat)
- nafcillin sodium (Unipen)
- nalidixic acid (NegGram)
- neomycin (Neo-Tabs, Mycifradin, Neo-fradin)
- novobiocin (Albamycin)
- oxacillin sodium
- paromomycin (Humatin)
- penicillin V (Pen Vee K Beepen-VK, Penicillin VK, Veetids)
- troleandomycin (Tao)
- vancomycin (Vancocin)
- and others
References
1 Cohen H, Scott SD, Mackie IJ, et al. The development of hypoprothrombinaemia following antibiotic therapy in malnourished patients with low serum vitamin K 1 levels. Br J Haematol 68: 63–66, 1988.
2 Conly J and Stein K. Reduction of vitamin K 2 concentrations in human liver associated with the use of broad spectrum antimicrobials. Clin Invest Med 17: 531–539, 1994.
3 Shearer MJ, Bechtold H, Andrassy K, et al. Mechanism of cephalosporin-induced hypoprothrombinemia: relation to cephalosporin side chain, vitamin K metabolism, and vitamin K status. J Clin Pharmacol 28: 88–95, 1988.
4 Goss TF, Walawander CA, Grasela TH, et al. Prospective evaluation of risk factors for antibiotic-associated bleeding in critically ill patients. Pharmacotherapy 12: 283–291, 1992.
5 Fuller R. Probiotics in human medicine. Gut 32: 439–442, 1991.
6 Elmer GW, Surawicz CM, and McFarland LV. Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. JAMA 275: 870–876, 1996.
7 Catanzaro JA and Green L. Microbial ecology and probiotics in human medicine (Part II). Alt Med Rev 2: 296–305, 1997.
8 Gorbach SL. Lactic acid bacteria and human health. Ann Med 22: 37–41, 1990.
9 Gotz V, Romankiewicz JA, Moss J, and Murray HW. Prophylaxis against ampicillin-associated diarrhea with a lactobacillus preparation. Am J Hosp Pharm 36: 754–757, 1979.
10 Colombel JF, Cortot A, Neut C, et al. Yoghurt with Bifidobacterium longum reduces erythromycin-induced gastrointestinal effects. Lancet. 1987;2:43.
11 Vanderhoof JA, Whitney DB, Antonson DL, et al. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr . 1999;135:564–568.
12 Tankanow RM, Ross MB, Ertel IJ, et al. A double-blind, placebo-controlled study of the efficacy of Lactinex in the prophylaxis of amoxicillin-induced diarrhea. DICP . 1990;24:382–384.
13 Surawicz CM, Elmer GW, Speelman P, et al. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology . 1989;96:981–988.
14 McFarland LV, Surawicz CM, Greenberg RN, et al. Prevention of Beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. Am J Gastroenterol . 1995;90:439–448.
15 Arvola T, Laiho K, Torkkeli S, et al. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics . 1999;104:e64.
16 Siitonen S, Vapaatalo H, Salminen S, et al. Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea. Ann Med . 1990;22:57–59.
17 Wullt M, Hagslatt ML, Odenholt I. Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial. Scand J Infect Dis . 2003;35(6-7):365-7.
18 Beniwal RS, Arena VC, Thomas L, et al. A randomized trial of yogurt for prevention of antibiotic-associated diarrhea. Dig Dis Sci . 2003;48:2077-82.
19 Correa NB, Peret Filho LA, Penna FJ et al. A Randomized Formula Controlled Trial of Bifidobacterium lactis and Streptococcus thermophilus for Prevention of Antibiotic-Associated Diarrhea in Infants. J Clin Gastroenterol . 2005;39:385-389.
20 Kotowska M, Albrecht P, Szajewska H et al. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther . 2005;21:583-90.
Revision Information
- Reviewer: EBSCO CAM Review Board
- Review Date: 07/2012 -
- Update Date: 07/25/2012 -